190 related articles for article (PubMed ID: 38647050)
1. Genome-wide screening and functional validation of methylation barriers near promoters.
Shu J; Jelinek J; Chen H; Zhang Y; Qin T; Li M; Liu L; Issa JJ
Nucleic Acids Res; 2024 May; 52(9):4857-4871. PubMed ID: 38647050
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
3. Methylation-specific loop-mediated isothermal amplification for detecting hypermethylated DNA in simplex and multiplex formats.
Zerilli F; Bonanno C; Shehi E; Amicarelli G; Adlerstein D; Makrigiorgos GM
Clin Chem; 2010 Aug; 56(8):1287-96. PubMed ID: 20551384
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
5. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
Qin Y; Liu JY; Li B; Sun ZL; Sun ZF
World J Gastroenterol; 2004 May; 10(9):1276-80. PubMed ID: 15112341
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
7. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
8. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
[TBL] [Abstract][Full Text] [Related]
10. Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer.
Betz B; Florl AR; Seifert HH; Dall P; Schulz WA; Niederacher D
Hum Mutat; 2004 Jun; 23(6):612-20. PubMed ID: 15146466
[TBL] [Abstract][Full Text] [Related]
11. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
12. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
13. The blues of P(16)INK(4a): aberrant promoter methylation and association with colorectal cancer in the Kashmir valley.
Sameer AS; Abdullah S; Nissar S; Rasool R; Shah ZA; Afroze D; Chowdri NA; Siddiqi MA
Mol Med Rep; 2012 Apr; 5(4):1053-7. PubMed ID: 22218684
[TBL] [Abstract][Full Text] [Related]
14. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
[TBL] [Abstract][Full Text] [Related]
15. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.
Shima K; Nosho K; Baba Y; Cantor M; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S
Int J Cancer; 2011 Mar; 128(5):1080-94. PubMed ID: 20473920
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of hMLH1 and p16INK4a in Tunisian patients with sporadic colorectal adenocarcinoma.
Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Biosci Rep; 2011 Aug; 31(4):257-64. PubMed ID: 20815811
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of CpG island methylation within divergent and unidirectional promoters in colorectal cancer.
Namba S; Sato K; Kojima S; Ueno T; Yamamoto Y; Tanaka Y; Inoue S; Nagae G; Iinuma H; Hazama S; Ishihara S; Aburatani H; Mano H; Kawazu M
Cancer Sci; 2019 Mar; 110(3):1096-1104. PubMed ID: 30637877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]